找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu

[復制鏈接]
樓主: Animosity
41#
發(fā)表于 2025-3-28 14:53:37 | 只看該作者
Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude
42#
發(fā)表于 2025-3-28 22:41:14 | 只看該作者
Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and
43#
發(fā)表于 2025-3-28 23:11:57 | 只看該作者
44#
發(fā)表于 2025-3-29 04:24:39 | 只看該作者
Kapitel 7: Erfassung sozialer Ph?nomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti
45#
發(fā)表于 2025-3-29 08:53:31 | 只看該作者
46#
發(fā)表于 2025-3-29 15:11:12 | 只看該作者
Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas
47#
發(fā)表于 2025-3-29 18:47:07 | 只看該作者
Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has
48#
發(fā)表于 2025-3-29 23:13:03 | 只看該作者
49#
發(fā)表于 2025-3-30 02:25:00 | 只看該作者
50#
發(fā)表于 2025-3-30 04:39:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
久治县| 唐河县| 平山县| 仙桃市| 尼玛县| 鄯善县| 神木县| 万州区| 阳高县| 嘉定区| 丰城市| 大港区| 龙胜| 濮阳县| 河南省| 连城县| 靖宇县| 泗洪县| 永胜县| 中江县| 南康市| 新兴县| 湘潭市| 刚察县| 黄浦区| 灌阳县| 辽阳县| 昆山市| 通渭县| 昂仁县| 普洱| 甘孜| 宜春市| 阆中市| 白银市| 大丰市| 天门市| 伊川县| 施甸县| 千阳县| 桃园县|